Antibodies are designed through specific biochemical processes
the verdict
SUPPORTED
the evidence backs this
confidence 86/100
Antibodies are routinely designed and engineered using specific biochemical and computational processes to enhance their binding affinity and therapeutic efficacy.
Evidence for · 4
Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches.
2019 · cited by 56
Discusses how antibody affinity and structure are improved through biochemical and computational maturation processes.
See more details
More for · 3
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
2024 · cited by 27
Details computational modelling and design strategies used to engineer synthetic nanobodies and optimize their binding domains.
Affinity maturation of cross-reactive CR3022 antibody against the receptor binding domain of SARS-CoV-2 via in silico site-directed mutagenesis
2020 · cited by 4
Presents a protocol for designing affinity-enhancing antibody mutants via in silico site-directed mutagenesis.
Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.
2026 · cited by 1
Demonstrates the rational, physics-informed design of nanobodies to optimize interfacial residues and binding affinity.